Direxion Daily S&P Biotech Bull 3x Shares (NYSEARCA:LABU) Trading Down 10.9% – Time to Sell?

Posted by Stacy Sanders on Mar 12th, 2026

Direxion Daily S&P Biotech Bull 3x Shares (NYSEARCA:LABU – Get Free Report) traded down 10.9% on Thursday . The company traded as low as $149.00 and last traded at $149.11. 517,133 shares were traded during trading, a decline of 20% from the average session volume of 648,546 shares. The stock had previously closed at $167.36.

Direxion Daily S&P Biotech Bull 3x Shares Price Performance

The stock’s 50-day moving average is $168.05 and its 200-day moving average is $137.59.

Institutional Investors Weigh In On Direxion Daily S&P Biotech Bull 3x Shares

A number of institutional investors have recently added to or reduced their stakes in LABU. Covestor Ltd acquired a new position in shares of Direxion Daily S&P Biotech Bull 3x Shares during the 4th quarter valued at $71,000. Qube Research & Technologies Ltd acquired a new position in Direxion Daily S&P Biotech Bull 3x Shares during the second quarter worth about $26,000. Thurston Springer Miller Herd & Titak Inc. raised its position in Direxion Daily S&P Biotech Bull 3x Shares by 68.7% in the third quarter. Thurston Springer Miller Herd & Titak Inc. now owns 506 shares of the company’s stock worth $47,000 after acquiring an additional 206 shares in the last quarter. Headlands Technologies LLC acquired a new stake in Direxion Daily S&P Biotech Bull 3x Shares in the 2nd quarter valued at about $69,000. Finally, Bank of America Corp DE boosted its position in shares of Direxion Daily S&P Biotech Bull 3x Shares by 134.2% during the 3rd quarter. Bank of America Corp DE now owns 2,476 shares of the company’s stock valued at $232,000 after purchasing an additional 1,419 shares in the last quarter.

About Direxion Daily S&P Biotech Bull 3x Shares

(Get Free Report)

The Direxion Daily S&P Biotech Bull 3X Shares (LABU) is an exchange-traded fund that is based on the S&P Biotechnology Select Industry index. The fund provides daily 3 times exposure to the S&P Biotechnology Select Industry Index. LABU was launched on May 28, 2015 and is managed by Direxion.